Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on OREX
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
Financials
Income Statement
Balance Sheet
Cash Flow Statement
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
Orexigen Therapeutics, Inc. (NQ:OREX)
Delayed:
6.40
-0.08 (1.23%)
Trade Now!
Previous Close
$6.48
52 Week High
$7.73
Open
$6.46
52 Week Low
$3.10
Day High
$6.47
P/E
N/A
Day Low
$6.30
EPS
$-1.32
Volume
503,061
Friends, Peers and Foes
(?)
:
ARNA
,
VVUS
,
GSK
,
RHHBY
,
ESRX
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 17, 2013 04:01 PM
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
May 10, 2013 04:01 PM
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 9, 2013 02:16 PM
Form 10-Q Orexigen Therapeutics, For: Mar 31
May 8, 2013 04:06 PM
Form 8-K Orexigen Therapeutics, For: May 08
May 8, 2013 04:01 PM
Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
May 3, 2013 08:43 AM
VIVUS, Inc. (VVUS) Ticks Higher as Arena (ARNA) Pulls BELVIQ MAA in Europe
May 2, 2013 08:31 AM
Orexigen Therapeutics to Host First Quarter 2013 Financial Results Conference Call and Webcast
Apr 25, 2013 04:35 PM
Orexigen Therapeutics Commends the Campaign to End Obesity's Report on Long-term Returns of Obesity Prevention Policies
Apr 22, 2013 08:35 AM
Orexigen CEO Michael Narachi Elected to PhRMA Board of Directors
Mar 13, 2013 04:03 PM
Orexigen Therapeutics, Inc. (OREX) Tops Q4 EPS by 3c; Updates on Contrave
View All Articles
Mar 13, 2013 04:03 PM
Orexigen Therapeutics, Inc. (OREX) Tops Q4 EPS by 3c; Updates on Contrave
Nov 7, 2012 04:16 PM
Orexigen Therapeutics, Inc. (OREX) Misses Q3 EPS by 14c
Oct 22, 2012 07:05 AM
Orexigen (OREX) Said FDA Supports Faster Path to Resubmission of the Contrave NDA, Study Enrollment Surpasses 7K
Aug 7, 2012 07:31 AM
Orexigen Therapeutics, Inc. (OREX) Posts Q2 Loss of 25c/Share, Wider than Views
May 9, 2012 04:00 PM
Orexigen Therapeutics, Inc. (OREX) Misses Q1 EPS by 4c
Mar 8, 2012 04:01 PM
Orexigen Therapeutics, Inc. (OREX) Posts Q4 Loss of 9c/Share
Aug 8, 2011 04:08 PM
Orexigen Therapeutics, Inc. (OREX) Tops Q2 EPS by 4c
View All Major News
May 3, 2013 08:43 AM
VIVUS, Inc. (VVUS) Ticks Higher as Arena (ARNA) Pulls BELVIQ MAA in Europe
Mar 13, 2013 04:03 PM
Orexigen Therapeutics, Inc. (OREX) Tops Q4 EPS by 3c; Updates on Contrave
Feb 21, 2013 12:56 PM
Risks vs. Benefits of Bariatric Surgery Might Put Obesity Pills in Lime Light (ARNA) (VVUS) (OREX)
Feb 4, 2013 10:45 AM
VIVUS, Inc. (VVUS) Qsymia Prescriptions Show Gains During Slow Holiday Week (ARNA) (OREX)
Feb 1, 2013 08:16 AM
VIVUS (VVUS) Peers Tick Higher Amid Positive Qsymia Data (ARNA) (OREX)
Jan 28, 2013 12:40 PM
Shorts Target VIVUS (VVUS) Following January Pop; May be Entering 'Oversold' Territory
Jan 22, 2013 01:48 PM
Obesity Pill Makers in Focus as EMA CHMP Denies Belviq MAA (ARNA) (VVUS) (OREX)
Jan 17, 2013 07:41 AM
Brean Capital Downgrades Vivus (VVUS) to Sell, Low Qsymia Coverage Means Low Sales
Jan 8, 2013 02:11 PM
Arena (ARNA) Chugs Higher on Volume; Will Present at JP Morgan Conf. Tomorrow
Jan 7, 2013 08:31 AM
Orexigen (OREX) Updates on Goal for Faster Contrave NDA Resubmission
View All Reports
May 17, 2013 04:01 PM
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
May 10, 2013 04:01 PM
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 8, 2013 04:01 PM
Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
May 2, 2013 08:31 AM
Orexigen Therapeutics to Host First Quarter 2013 Financial Results Conference Call and Webcast
Apr 25, 2013 04:35 PM
Orexigen Therapeutics Commends the Campaign to End Obesity's Report on Long-term Returns of Obesity Prevention Policies
Apr 22, 2013 08:35 AM
Orexigen CEO Michael Narachi Elected to PhRMA Board of Directors
View All Press Releases
May 9, 2013 02:16 PM
Form 10-Q Orexigen Therapeutics, For: Mar 31
May 8, 2013 04:06 PM
Form 8-K Orexigen Therapeutics, For: May 08
View All Filings
Entities mentioned with
OREX
Earnings
|
View Related Stories »
Bank of America
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
JPMorgan
|
View Related Stories »
Morning Movers
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Unusual 11 Mid-Day Movers
|
View Related Stories »
Dividend
|
View Related Stories »
Credit Suisse
|
View Related Stories »
Citi
|
View Related Stories »
Bankruptcy
|
View Related Stories »
Needham & Company
|
View Related Stories »
Options
|
View Related Stories »
Brean Murray Carret & Co.
|
View Related Stories »
Lazard
|
View Related Stories »
After-Hours Movers
|
View Related Stories »
Morgan Stanley
|
View Related Stories »
Cowen & Co
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
Stifel Nicolaus
|
View Related Stories »
BMO Capital
|
View Related Stories »
RBC Capital
|
View Related Stories »
Crude Oil
|
View Related Stories »
Davenport
|
View Related Stories »
Pre-Open Winners
|
View Related Stories »
Show More...
View All Entities